U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on DARA Biosciences and PDL BioPharma

Continue Reading

EIA and OPEC Raise Forecasts for Global Oil Demand in 2013

Five Star Equities Provides Stock Research on Hyperdynamics and Petroquest Energy

Continue Reading

Earnings Help Fuel S&P 500 Index Rally — S&P 500 Index Tops 1500 Mark for the First Time in 5 Years

Five Star Equities Provides Stock Research on Bristol Myers Squibb and Pfizer

Continue Reading

Uranium Industry Will Look to Rally in 2013 on the Resurgence of Japanese Demand for Nuclear Power

RDInvesting Provides Stock Research on Uranerz Energy and Paladin Energy

Continue Reading

Improvements in the Global Economy to Drive Global Demand for Oil Higher in 2013

Five Star Equities Provides Stock Research on Abraxas Petroleum and Lone Pine Resources

Continue Reading

Approximately 74% of S&P 500 Companies That have Reported Earnings Have Exceeded Projections

Five Star Equities Provides Stock Research on Avon Products and Campbell Soup Company

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Affymax and Incyte

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on NPS Pharmaceuticals and Oncothyreon

Continue Reading

Oil Industry to Benefit From Growing Global Oil Demand in 2013

Five Star Equities Provides Stock Research on Denbury Resources and Talisman Energy

Continue Reading

Positive Outlook for Oil Industry in 2013 as EIA and OPEC Raise Forecasts for Global Oil Demand

Five Star Equities Provides Stock Research on Hercules Offshore and Seadrill

Continue Reading